Product References
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
Molecular carcinogenesis
Li J,Wan F,Zhang J,Zheng S,Yang Y,Hong Z,Dai B
Sat Jul 01 00:00:00 EDT 2023
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
Molecular carcinogenesis
Li J,Wan F,Zhang J,Zheng S,Yang Y,Hong Z,Dai B
Sat Jul 01 00:00:00 EDT 2023
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
Molecular carcinogenesis
Li J,Wan F,Zhang J,Zheng S,Yang Y,Hong Z,Dai B
Sat Jul 01 00:00:00 EDT 2023
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c-Myc signaling.
Molecular carcinogenesis
Li J,Wan F,Zhang J,Zheng S,Yang Y,Hong Z,Dai B
Sat Jul 01 00:00:00 EDT 2023
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Aging
Su Z,Su H,Xu J,Wei G,Qu L,Ni T,Yang D,Zhu Y
Wed Dec 28 00:00:00 EST 2022
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Aging
Su Z,Su H,Xu J,Wei G,Qu L,Ni T,Yang D,Zhu Y
Wed Dec 28 00:00:00 EST 2022
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Aging
Su Z,Su H,Xu J,Wei G,Qu L,Ni T,Yang D,Zhu Y
Wed Dec 28 00:00:00 EST 2022
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Aging
Su Z,Su H,Xu J,Wei G,Qu L,Ni T,Yang D,Zhu Y
Wed Dec 28 00:00:00 EST 2022
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Aging
Su Z,Su H,Xu J,Wei G,Qu L,Ni T,Yang D,Zhu Y
Wed Dec 28 00:00:00 EST 2022
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
Aging
Su Z,Su H,Xu J,Wei G,Qu L,Ni T,Yang D,Zhu Y
Wed Dec 28 00:00:00 EST 2022
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation.
Cell death & disease
Su H,Meng C,Xu J,Su Z,Xiao C,Yang D
Fri Oct 21 00:00:00 EDT 2022
STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells.
Journal of molecular neuroscience : MN
Pan K,Hu B,Wang L,Yuan J,Xu W
Thu Sep 01 00:00:00 EDT 2022
STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells.
Journal of molecular neuroscience : MN
Pan K,Hu B,Wang L,Yuan J,Xu W
Thu Sep 01 00:00:00 EDT 2022
Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2.
Cancers
Siddique AB,Ebrahim HY,Tajmim A,King JA,Abdelwahed KS,Abd Elmageed ZY,El Sayed KA
Thu Jul 21 00:00:00 EDT 2022
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma.
Journal of Cancer
Zuo SR,Zuo XC,He Y,Fang WJ,Wang CJ,Zou H,Chen P,Huang LF,Huang LH,Xiang H,Liu SK
Fri Apr 08 00:00:00 EDT 2022
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma.
Journal of Cancer
Zuo SR,Zuo XC,He Y,Fang WJ,Wang CJ,Zou H,Chen P,Huang LF,Huang LH,Xiang H,Liu SK
Fri Apr 08 00:00:00 EDT 2022
SMYD2 targets RIPK1 and restricts TNF-induced apoptosis and necroptosis to support colon tumor growth.
Cell death & disease
Yu YQ,Thonn V,Patankar JV,Thoma OM,Waldner M,Zielinska M,Bao LL,Gonzalez-Acera M,Wallmüller S,Engel FB,Stürzl M,Neurath MF,Liebing E,Becker C
Wed Jan 12 00:00:00 EST 2022
SMYD2 suppresses p53 activity to promote glucose metabolism in cervical cancer.
Experimental cell research
Wang Y,Jin G,Guo Y,Cao Y,Niu S,Fan X,Zhang J
Thu Jul 15 00:00:00 EDT 2021
SMYD2 suppresses APC2 expression to activate the Wnt/β-catenin pathway and promotes epithelial-mesenchymal transition in colorectal cancer.
American journal of cancer research
Meng F,Liu X,Lin C,Xu L,Liu J,Zhang P,Zhang X,Song J,Yan Y,Ren Z,Zhang Y
Mon Sep 28 00:00:00 EDT 2020
SMYD2 suppresses APC2 expression to activate the Wnt/β-catenin pathway and promotes epithelial-mesenchymal transition in colorectal cancer.
American journal of cancer research
Meng F,Liu X,Lin C,Xu L,Liu J,Zhang P,Zhang X,Song J,Yan Y,Ren Z,Zhang Y
Mon Sep 28 00:00:00 EDT 2020
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma.
Theranostics
Yan L,Ding B,Liu H,Zhang Y,Zeng J,Hu J,Yao W,Yu G,An R,Chen Z,Ye Z,Xing J,Xiao K,Wu L,Xu H
Mon Sep 14 00:00:00 EDT 2020
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
Cell reports
Zeng Y,Qiu R,Yang Y,Gao T,Zheng Y,Huang W,Gao J,Zhang K,Liu R,Wang S,Hou Y,Yu W,Leng S,Feng D,Liu W,Zhang X,Wang Y
Tue Nov 05 00:00:00 EST 2019
SMYD2 Drives Mesendodermal Differentiation of Human Embryonic Stem Cells Through Mediating the Transcriptional Activation of Key Mesendodermal Genes.
Stem cells (Dayton, Ohio)
Bai HJ,Zhang P,Ma L,Liang H,Wei G,Yang HT
Fri Nov 01 00:00:00 EDT 2019
Proteomic analysis of seminal extracellular vesicle proteins involved in asthenozoospermia by iTRAQ.
Molecular reproduction and development
Lin Y,Liang A,He Y,Li Z,Li Z,Wang G,Sun F
Sun Sep 01 00:00:00 EDT 2019